Today I was notified that my NIH RO1 grant got a score of 1%. I am so excited!
Michael Wang, MD
3,130 posts
Michael Wang, MD
@michaelwangmd
Puddin Clarke Endowed Professor, #Lymphoma/#Myeloma @MDAndersonnews; #mantlecelllymphoma, B-Cell Lymphoma Moonshot, MD Anderson bit.ly/2DP6agv views=own
- My 82 yo mother was stranded in the storm in a flooded car this pm. A kind Spanish speaking couple invited her to their car and took her to their home. I drove 5 hours in rain through high waters and got her. I thanked the couple. They are my heroes today!
- In a world pandemic, with nonstop bad news, a little but beautiful flower of cell therapy for MCL blossomed quietly! Even on April Fools’ day, this is no joke! This is a most exciting milestone for relapsed #mantlecelllymphoma. This is unprecedented great news for our patients!
- Today I was notified by the Chief Academic Officer that I have been appointed to be the Puddin Clarke Endowed Professor as of December 1, 2019. I feel much appreciated and extremely honored by my beloved MD Anderson institution!
- Last weekend I was invited to a party by a good friend. When I got there, I saw 30 people eating next to each other around tables in the backyard, no masks. They told me all tested negative for COVID. I smiled and left. Cannot put my patients and family at risk.
- Thirty four years ago today I came to America. It has been quite a dream.
- Congratulations to all patients and their families affected by mantle cell lymphoma! This is a milestone progress! U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma | Gilead Sciences investors.gilead.com/news-releases/…
- My patient from Alaska in remission after chemo free therapy for MCL!
- My wife sent this photo to me from Africa, I wish I was there!
- Today I am pacing the quiet floors of MD Anderson, rounding on our patients.
- Today I got a certificate for having served for 20 years at MD Anderson. It has been quite a unique journey!
- To all patients and families affected by #mantlecelllymphoma, we now have another magic bullet to treat MCL, this is wonderful news for you, congratulations! Many of you together with a big international team worked on this trial, it is a great team effort!Replying to @UTMDAnderson“Oral pirtobrutinib could be used even after failure of prior BTK inhibitors and will benefit mantle cell lymphoma patients tremendously,” Wang says. “This is a milestone achievement in mantle cell lymphoma therapy.” bit.ly/3JlSdK5 @MichaelWangMD #EndCancer [2/2]
- On my way to ASH with my wonderful colleague, Dr. Jason Westin!
- Today, I got a punching bag, it has “MCL” on it, I could now exercise in my office!
